Pfizer-BioNTech COVID vaccines effective, safe for children aged 6 months to 4 years: USFDA staff Ruchika Sharma13 Jun 2022 1:45 PM ISTAn early analysis of data from Pfizer-BioNTech's vaccine based on 10 symptomatic COVID-19 cases identified when the Omicron coronavirus variant was...
Africa to get BioNTech mRNA vaccine factory soon Ruchika Sharma12 Jun 2022 9:00 AM ISTBioNTech has said the BioNTainers could make other mRNA vaccines against malaria or tuberculosis, depending on product development progress and future...
Moderna coronavirus vaccine effective for kids under five years: USFDA Ruchika Sharma11 Jun 2022 2:15 PM ISTEven though Moderna's vaccine has proven less effective against the Omicron variant, it remains very good at protecting against severe cases of the...
FIRST: COVID vaccine for animals launched in India Ruchika Sharma11 Jun 2022 1:20 PM ISTThe vaccine contains inactivated SARS-CoV-2 (Delta) antigen with Alhydrogel as an adjuvant. It is safe for dogs, lions, leopards, mice and rabbits, it...
Bivalent booster demonstrates superior antibody response against Omicron: Moderna Ruchika Sharma9 Jun 2022 3:17 PM IST"Moderna is planning to submit the interim analysis and data to regulators for review in the coming weeks," the company further stated.
Novavax COVID shot gets USFDA Advisory Committee recommendation for emergency use nod for 18 years and older Ruchika Sharma8 Jun 2022 12:14 PM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
SII to produce Novavax COVID vaccine for US Ruchika Sharma8 Jun 2022 10:00 AM ISTNew Delhi: Novavax Inc said on Tuesday that its COVID-19 vaccine initially available in the United States, if authorized, will be manufactured by the...
JnJ to terminate COVID vaccine agreement with Emergent BioSolutions Ruchika Sharma7 Jun 2022 4:33 PM ISTIf the agreement is terminated, Emergent said J&J would owe it roughly $125 million to $420 million.
DCGI nod to Biological E Corbevax as heterologous COVID booster Ruchika Sharma5 Jun 2022 12:00 PM ISTBE's CORBEVAX is the first such vaccine in India to be approved as a heterologous COVID-19 booster.
USFDA flags heart inflammation risk after taking Novavax COVID vaccine Ruchika Sharma4 Jun 2022 3:09 PM ISTThe FDA said it had requested Novavax to flag myocarditis and another kind of heart inflammation as an "important identified risk" in its materials.
Walvax Biotechnology COVID booster stronger against Omicron than Sinovac shot, shows trial data Ruchika Sharma4 Jun 2022 10:00 AM ISTBeijing: A COVID-19 vaccine candidate from China's Walvax Biotechnology using mRNA technology triggered a stronger antibody response against the...
Women more likely to develop skin rash from Moderna COVID vaccine, says Japanese study Roshni Dhar3 Jun 2022 6:00 PM ISTA study in Japan found that women were significantly more likely than men to develop rash-like side effects after a first dose of Moderna Inc's...
